Can and should value-based pricing be applied to molecular diagnostics?. Garau, M., Towse, A., Garrison, L., Housman, L., & Ossa, D. Personalized Medicine, 10(1):61–72, January, 2013.
Can and should value-based pricing be applied to molecular diagnostics? [link]Paper  doi  bibtex   
@article{garau_can_2013-1,
	title = {Can and should value-based pricing be applied to molecular diagnostics?},
	volume = {10},
	issn = {1741-0541, 1744-828X},
	url = {https://www.futuremedicine.com/doi/10.2217/pme.12.99},
	doi = {10.2217/pme.12.99},
	language = {en},
	number = {1},
	urldate = {2019-05-02},
	journal = {Personalized Medicine},
	author = {Garau, Martina and Towse, Adrian and Garrison, Louis and Housman, Laura and Ossa, Diego},
	month = jan,
	year = {2013},
	pages = {61--72},
	file = {Garau et al. - 2013 - Can and should value-based pricing be applied to m.pdf:/Users/neil.hawkins/Zotero/storage/968YPURK/Garau et al. - 2013 - Can and should value-based pricing be applied to m.pdf:application/pdf},
}

Downloads: 0